Risk of recurrence after diagnosis of invasive breast cancer by molecular subtype as defined by ER, PR and her2 status [ 2012 - 2015 ]

Research Grant

Researchers: Dr Laura Baglietto (Principal investigator) ,  Prof Dallas English (Principal investigator) ,  Prof Gregory Mann

Brief description Breast cancer is a heterogeneous disease. Molecular subtypes have been identified that differ in terms of prognosis and response to treatment. This study aims to estimate recurrence free survival of breast cancer by molecular subtypes in a population-based sample of Australian women. The results will assist clinicians to guide their therapeutic decisions and will inform women about their anticipated outcome after diagnosis of breast cancer.

Funding Amount $AUD 500,622.73

Funding Scheme Project Grants

Notes Standard Project Grant